BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Velikova T, Krastev B, Gulinac M, Zashev M, Graklanov V, Peruhova M. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis. World J Clin Cases 2024; 12(6): 1050-1062 [PMID: 38464930 DOI: 10.12998/wjcc.v12.i6.1050]
URL: https://www.wjgnet.com/1948-5204/full/v12/i6/1050.htm
Number Citing Articles
1
Qianjie Xu, Xiaosheng Li, Yuliang Yuan, Guangzhong Liang, Zuhai Hu, Wei Zhang, Ying Wang, Haike Lei. Development and validation of a nomogram for predicting immune-mediated colitis in lung cancer patients treated with immune checkpoint inhibitors: a retrospective cohort study in ChinaFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1510053
2
Wei Ming Ong, Samiha Arulshankar, Glen Guerra, Vinna An, Suat Chin Ng. Immune-mediated Colitis – An Update for SurgeonsWorld Journal of Colorectal Surgery 2025; 14(3): 85 doi: 10.4103/wjcs.wjcs_21_25
3
Wen-zhe Yi, Xin-di Qian, Xiao-xuan Xu, Rong Pu, Dan Yan, Zhi-wen Zhao, Ya-ping Li, Dang-ge Wang. Dendritic cell-liposome conjugates reverse immunosuppressive tumor microenvironment for inhibiting colitis-associated colorectal cancerActa Pharmacologica Sinica 2025;  doi: 10.1038/s41401-025-01614-7
4
Carolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, Krishnavathana Varatharajalu, Anusha Thomas, Yinghong Wang. Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and managementImmunotherapy 2025; 17(4): 293 doi: 10.1080/1750743X.2025.2473305